+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Hemodialysis Vascular Grafts Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • ID: 4760565
  • Report
  • February 2019
  • Region: Global
  • Acute Market Reports
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • C.R.Bard, Inc.
  • CryoLife, Inc.
  • Getinge AB.
  • InnAVasc Medical, Inc.
  • LeMaitre Vascular, Inc.
  • Vascular Genesis
  • MORE
The global hemodialysis vascular grafts market is expected to reach from US$ 196.6 Mn in 2017 to US$ 285.2 Mn by 2026 expanding at a CAGR of 4.3% from 2018 to 2026.

Market Insights
End-stage renal disease (ESRD) is a medical condition in which the kidney functions only 10% of its natural ability to perform excretion of toxic material from the human blood. When the glomerular filtration rate of the kidney is < 15 ml/min/1.73 m2, the patient is reported with end-stage renal failure. Diabetes and hypertension are the chief causative factors in chronic kidney disease. Chronic kidney disease has a global prevalence rate between 11 to 13% in stage 3 ESRD. The role of vascular grafts in hemodialysis procedure is to attain blood flow from one area to the other by connecting blood vessels.

Polyurethane is mixed in different concentration to achieve vascular graft with improved tensile strength and larger inner luminal diameter to promote smooth blood transfusion during a hemodialysis procedure. Polytetrafluoroethylene currently dominates the raw material segment for hemodialysis vascular grafts market. Its inherent features such as high adhesion, excellent native fistula pliability, and reimbursement scenario drive the market growth. Bioengineered materials will be the latest trendsetter during the forecast period due to improved material characteristics which prevent infection, hemorrhage and graft rejection occurring during hemodialysis procedure in patients suffering from chronic kidney disease.

With a market share of 36%, North America is the largest regional market in hemodialysis vascular grafts market. The properties influencing its dominant growth are increasing geriatric population suffering from end-stage renal disease and higher healthcare expenditure. The existence of market leaders such as C.R.Bard, Inc., Terumo Medical Corporation and CryoLife, Inc., etc. further propel the hemodialysis vascular grafts market in the North America region. Europe currently holds a 28% share owing to features such as supportive reimbursement scenario associated with hemodialysis vascular grafts and increasing demand for hemodialysis procedures compared to intraperitoneal dialysis in patients suffering from chronic kidney disease. The Asia Pacific represents a 20% share and is set to engrave positive growth in the near future due to proactive government policies to fight renal disease and rapid growth in medical tourism.

Pharmaceutical companies manufacturing hemodialysis vascular grafts are C.R.Bard, Inc., CryoLife, Inc., Getinge AB., InnAVasc Medical, Inc., LeMaitre Vascular, Inc., Merit Medical Systems, Inc., Proteon Therapeutics, Inc., Terumo Medical Corporation, Vascular Genesis and W.L.Gore Associates.

Key Market Movements
  • Increasing morbidity associated with hemodialysis procedures in patients suffering from end-stage renal diseases
  • Different blends of synthetic polymers are mixed e.g. polyurethane and polytetrafluoroethylene to achieve the desired native fistula pliability and adhesion properties
  • Technical innovations in bioengineered raw materials to drastically reduce infection, graft rejection and hemorrhage occurring in hemodialysis procedures
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • C.R.Bard, Inc.
  • CryoLife, Inc.
  • Getinge AB.
  • InnAVasc Medical, Inc.
  • LeMaitre Vascular, Inc.
  • Vascular Genesis
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Raw Materials
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Hemodialysis Vascular Grafts Market Portraiture
2.2. Global Hemodialysis Vascular Grafts Market, by Raw Material, 2017 (US$ Mn)
2.3. Global Hemodialysis Vascular Grafts Market, by Geography, 2017 (US$ Mn)

Chapter 3. Hemodialysis Vascular Grafts Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Hemodialysis Vascular Grafts Market, by Key Players, 2017

Chapter 4. Global Hemodialysis Vascular Grafts Market, by Raw Material
4.1. Overview
4.2. Polyurethane
4.3. Polyester
4.4. Polytetrafluoroethylene
4.5. Biological Material

Chapter 5. Global Hemodialysis Vascular Grafts Market, by Geography
5.1. Overview
5.2. North America Hemodialysis Vascular Grafts Market Analysis, 2016 – 2026
5.2.1. North America Hemodialysis Vascular Grafts Market, by Raw Material, 2016 – 2026 (US$ Mn)
5.2.2. North America Hemodialysis Vascular Grafts Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Hemodialysis Vascular Grafts Market Analysis, 2016 – 2026
5.3.1. Europe Hemodialysis Vascular Grafts Market, by Raw Material, 2016 – 2026 (US$ Mn)
5.3.2. Europe Hemodialysis Vascular Grafts Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Hemodialysis Vascular Grafts Market Analysis, 2016 – 2026
5.4.1. Asia Pacific Hemodialysis Vascular Grafts Market, by Raw Material, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific Hemodialysis Vascular Grafts Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America Hemodialysis Vascular Grafts Market Analysis, 2016 – 2026
5.5.1. Latin America Hemodialysis Vascular Grafts Market, by Raw Material, 2016 – 2026 (US$ Mn)
5.5.2. Latin America Hemodialysis Vascular Grafts Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa Hemodialysis Vascular Grafts Market Analysis, 2016 – 2026
5.6.1. MEA Hemodialysis Vascular Grafts Market, by Raw Material, 2016 – 2026 (US$ Mn)
5.6.2. MEA Hemodialysis Vascular Grafts Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. C.R.Bard, Inc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. CryoLife, Inc.
6.3. Getinge AB.
6.4. InnAVasc Medical, Inc.
6.5. LeMaitre Vascular, Inc.
6.6. Merit Medical Systems, Inc.
6.7. Proteon Therapeutics, Inc.
6.8. Terumo Medical Corporation
6.9. Vascular Genesis
6.10. W.L.Gore & Associates

List of Figures
Figure 1 Hemodialysis Vascular Grafts Market: Research Methodology
Figure 2 Hemodialysis Vascular Grafts: Market Segmentation
Figure 3 Global Hemodialysis Vascular Grafts Market, by Raw Material, 2017 (US$ Mn)
Figure 4 Global Hemodialysis Vascular Grafts Market, by Geography, 2017 (US$ Mn)
Figure 5 Attractive Investment Proposition: by Geography, 2017
Figure 6 Competitive Analysis: Global Hemodialysis Vascular Grafts Market, by Key Players, 2017
Figure 7 Global Polyurethane Market for Hemodialysis Vascular Grafts, 2016 – 2026 (US$ Mn)
Figure 8 Global Polyester Market for Hemodialysis Vascular Grafts, 2016 – 2026 (US$ Mn)
Figure 9 Global Polytetrafluoroethylene Market for Hemodialysis Vascular Grafts, 2016 – 2026 (US$ Mn)
Figure 10 Global Biological Material Market for Hemodialysis Vascular Grafts, 2016 – 2026 (US$ Mn)
Figure 11 U.S. Hemodialysis Vascular Grafts Market, 2016 – 2026 (US$ Mn)
Figure 12 Canada Hemodialysis Vascular Grafts Market, 2016 – 2026 (US$ Mn)
Figure 13 U.K. Hemodialysis Vascular Grafts Market, 2016 – 2026 (US$ Mn)
Figure 14 Germany Hemodialysis Vascular Grafts Market, 2016 – 2026 (US$ Mn)
Figure 15 Rest of Europe Hemodialysis Vascular Grafts Market, 2016 – 2026 (US$ Mn)
Figure 16 China Hemodialysis Vascular Grafts Market, 2016 – 2026 (US$ Mn)
Figure 17 Japan Hemodialysis Vascular Grafts Market, 2016 – 2026 (US$ Mn)
Figure 18 Rest of Asia Pacific Hemodialysis Vascular Grafts Market, 2016 – 2026 (US$ Mn)
Figure 19 Brazil Hemodialysis Vascular Grafts Market, 2016 – 2026 (US$ Mn)
Figure 20 Mexico Hemodialysis Vascular Grafts Market, 2016 – 2026 (US$ Mn)
Figure 21 Rest of Latin America Hemodialysis Vascular Grafts Market, 2016 – 2026 (US$ Mn)
Figure 22 GCC Hemodialysis Vascular Grafts Market, 2016 – 2026 (US$ Mn)
Figure 23 Rest of Middle East and Africa Hemodialysis Vascular Grafts Market, 2016 – 2026 (US$ Mn)

List of Tables
Table 1 Global Hemodialysis Vascular Grafts Market Portraiture
Table 2 Global Hemodialysis Vascular Grafts Market, by Raw Material, 2016 – 2026 (US$ Mn)
Table 3 Global Hemodialysis Vascular Grafts Market, by Geography, 2016 – 2026 (US$ Mn)
Table 4 North America Hemodialysis Vascular Grafts Market, by Raw Material, 2016 – 2026 (US$ Mn)
Table 5 North America Hemodialysis Vascular Grafts Market, by Country, 2016 – 2026 (US$ Mn)
Table 6 Europe Hemodialysis Vascular Grafts Market, by Raw Material, 2016 – 2026 (US$ Mn)
Table 7 Europe Hemodialysis Vascular Grafts Market, by Country/Region, 2016 – 2026 (US$ Mn)
Table 8 Asia Pacific Hemodialysis Vascular Grafts Market, by Raw Material, 2016 – 2026 (US$ Mn)
Table 9 Asia Pacific Hemodialysis Vascular Grafts Market, by Country/Region, 2015 – 2025 (US$ Mn)
Table 10 Latin America Hemodialysis Vascular Grafts Market, by Raw Material, 2016 – 2026 (US$ Mn)
Table 11 Latin America Hemodialysis Vascular Grafts Market, by Country/Region, 2016 – 2026 (US$ Mn)
Table 12 Middle East and Africa Hemodialysis Vascular Grafts Market, by Raw Material, 2016 – 2026 (US$ Mn)
Table 13 Middle East and Africa Hemodialysis Vascular Grafts Market, by Region, 2016 – 2026 (US$ Mn)
Table 14 C.R.Bard, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 15 CryoLife, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 16 Getinge AB.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 17 InnAVasc Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 18 LeMaitre Vascular, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 19 Merit Medical Systems, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 20 Proteon Therapeutics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 21 Terumo Medical Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 22 Vascular Genesis: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 23 W.L.Gore & Associates: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • C.R.Bard, Inc.
  • CryoLife, Inc.
  • Getinge AB.
  • InnAVasc Medical, Inc.
  • LeMaitre Vascular, Inc.
  • Merit Medical Systems, Inc.
  • Proteon Therapeutics, Inc.
  • Terumo Medical Corporation
  • Vascular Genesis
  • W.L.Gore & Associates
Note: Product cover images may vary from those shown
Adroll
adroll